As a result of recommendations proposed by NACI, ON is likely to approve interchangeability for vaccines sometime this week. This means patients who have taken AZ for their dose 1 may be eligible to take a mRNA vaccine for dose 2. In turn, ON has created an additional consent form to guide patient's through their selection of a dose 2. To best implement this consent form and interchangeability into your workflow we have a few considerations:
1) Are you going to be receiving both AZ and mRNA vaccine supply simultaneously?
2) How would you feel about AZ dose 1 patients calling the pharmacy if they desired an alternative mRNA vaccine for dose 2?
3) Any recommendations that you have, which would make this transition more manageable for the pharmacy and patients
UPDATES - please feel free to comment on the below direction:
1) A mass rescheduling feature will be implemented shortly to help move booked appointments to a different dates en-masse
2) Our potential solutions for collecting preferred dose 2 brand information:
  • For patients on the Dose 2 Waitlist: Option found on the Dose 2 Waitlist tab to send an email where patients are prompted to either stay on the AZ dose 2 waitlist OR switch over to a dose 2 mRNA waitlist
  • When sending booking links to patients on the Dose 2 Waitlist OR when sending rescheduling links to patients with booked Dose 2 appointments: Give patients the option to switch to a dose 2 mRNA waitlist or continue to booking when links are sent out